Kah Meng Lim

Chief Executive Officer chez COMPASS VENTURE INC. Fortune : 64 800 $ au 30/11/2023

Profil

Kah Meng Lim is the founder of Gene Oasis Pte Ltd.
He is currently the Chief Executive Officer & Director at Compass Venture, Inc., Chief Executive Officer at Zenzic Labs Pte Ltd., Chief Executive Officer at NGF Bioenterprise Pte Ltd., Director at GDX Corp., Independent Non-Executive Director at Singapore Paincare Holdings Ltd., Director at CanniOasis Pte Ltd., and Director at Betalife Pte Ltd.
Dr. Lim previously worked as an Associate Professor at Tianjin University from 2014 to 2017.
He received his doctorate degree from Yong Loo Lin School of Medicine in 2001.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
COMPASS VENTURE, INC. 7,08%	26/10/2022	400 000 ( 7,08% )	64 800 $	30/11/2023

Postes actifs de Kah Meng Lim

Sociétés	Poste	Début
COMPASS VENTURE INC.	Chief Executive Officer	02/01/2019
SINGAPORE PAINCARE HOLDINGS LIMITED	Director/Board Member	05/03/2021
Zenzic Labs Pte Ltd.	Chief Executive Officer	01/01/2019
NGF Bioenterprise Pte Ltd.	Chief Executive Officer	01/01/2017
GDX Corp.	Director/Board Member	01/01/2019

Anciens postes connus de Kah Meng Lim

Sociétés	Poste	Fin
Tianjin University	Corporate Officer/Principal	01/01/2017
Gene Oasis Pte Ltd.	Founder	-

Formation de Kah Meng Lim

Yong Loo Lin School of Medicine

Doctorate Degree